Oryzon Genomics SA (ORYZF)
3.098
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Oryzon Genomics Price : 3.098 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 06, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 05, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 02, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Oct 01, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 0.000 |
| Sep 30, 2026 | 3.098 | 3.098 | 3.098 | 3.098 | 3000.00 |
| Sep 29, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 28, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 25, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 24, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 23, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 22, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 21, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 18, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 17, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 16, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 15, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 14, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 11, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 10, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 0.000 |
| Sep 09, 2026 | 3.31 | 3.31 | 3.31 | 3.31 | 400.00 |
| Sep 08, 2026 | 3.27 | 3.27 | 3.27 | 3.27 | 0.000 |
| Sep 04, 2026 | 3.27 | 3.27 | 3.27 | 3.27 | 0.000 |
| Sep 03, 2026 | 3.27 | 3.27 | 3.27 | 3.27 | 0.000 |
| Sep 02, 2026 | 3.27 | 3.27 | 3.27 | 3.27 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pharma Mar SA | 94.60 |
| Grifols SA | 7.50 |
| ACADIA Pharmaceuticals, Inc. | 19.65 |
| Alkermes Plc | 41.44 |
| Alnylam Pharmaceuticals, Inc. | 224.41 |
Price Related Metrics
| Price to Book Value | 2.015 |
| Earnings Yield | -1.15% |
| Market Cap | 240.11M |